Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of the p38 MAPK pathway in cisplatin-based therapy.

Oncogene - 26 Jun 2003

Hernández Losa Javier, Parada Cobo Carlos, Guinea Viniegra Juan, Sánchez-Arevalo Lobo Victor Javier, Ramón y Cajal Santiago, Sánchez-Prieto Ricardo

Abstract excerpt

p38 MAPK has been implicated in the response to cancer therapy. To determine whether the activation of p38 MAPK could be specific to cancer therapy, we investigated the activation of p38 MAPK in response to several chemotherapeutic agents, such as cisplatin, doxorubicin and taxol in several human cell lines. Activation of p38 MAPK was measured after exposure to several chemotherapeutic agents, using specific...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calcium-Calmodulin-Dependent Protein Kinases
Share to Cisplatin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross-Linking Reagents

Share to Dose-Response Relationship, Radiation

Share to Mitogen-Activated Protein Kinase Kinases

Share to p38 Mitogen-Activated Protein Kinases

Share to Platinum Compounds

Share to Thiazoles

Source

Identifiers

PMID: 12821934
DOI: 10.1038/sj.onc.1206608

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of the p38 MAPK pathway in cisplatin-based therapy.PMID 12821934Read ↗

p38δ MAPK phenotype: an indicator of chemotherapeutic response in oesophageal squamous cell carcinoma.Semantic proximity Read ↗

p38 MAPK Molecular Targeting for Next-Generation Multiple Myeloma TherapySemantic proximity Read ↗

CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin.Semantic proximity Read ↗

Role of tyrosine kinase-independent phosphorylation of EGFR with activating mutation in cisplatin-treated lung cancer cells.Semantic proximity Read ↗

Role of p38 MAPK in the cytokine reprogramming of a human leukemic cell line with a drug-resistant phenotype.Semantic proximity Read ↗

Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cellsSemantic proximity Read ↗

Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activationSemantic proximity Read ↗

Molecular alterations of cells resistant to platinum drugs: role of PKCalpha.Semantic proximity Read ↗

Resistance to Paclitaxel in a Cisplatin-Resistant Ovarian Cancer Cell Line Is Mediated by P-GlycoproteinSemantic proximity Read ↗

Regulation of platinum-compound cytotoxicity by the c-Jun N-terminal kinase and c-Jun signaling pathway in small-cell lung cancer cells.Semantic proximity Read ↗

Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivoSemantic proximity Read ↗

Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell linesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.